Cart
sales@molnova.com
CBP-IN-1
CAS No. 2222941-37-7
CBP-IN-1( —— )
Catalog No. M22843 CAS No. 2222941-37-7
CBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 174 | In Stock |
|
| 2MG | 88 | In Stock |
|
| 5MG | 147 | In Stock |
|
| 10MG | 264 | In Stock |
|
| 25MG | 558 | In Stock |
|
| 50MG | 780 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCBP-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.
-
DescriptionCBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.
-
In Vitro——
-
In VivoAnimal Model:Noncastrated male athymic nude mice Dosage:10-30 mg/kg Administration:Oral gavage; at 10 or 20 mg/kg daily (QD) or at 30 mg/kg every other day (QOD) for 28 days Result:Affected tumor growth at 10 mg/kg daily, 20 mg/kg daily, and 30 mg/kg every other day.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptorp300/CBP
-
Research Areacancer
-
IndicationHaematological Malignancy|Acute Myeloid Leukemia|Non Hodgkin Lymphoma|Multiple Myeloma
Chemical Information
-
CAS Number2222941-37-7
-
Formula Weight534.6
-
Molecular FormulaC30H32F2N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (187.06 mM; Need ultrasonic)
-
SMILESO=C1N(C2=CC=C(F)C(F)=C2)[C@H](C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@H]6CC[C@H](OC)CC6)CCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Neil Anthony Pegg, et al. Pharmaceutical compounds. WO2018073586A1.
molnova catalog
related products
-
J147
J-147 is a broad spectrum neuroprotective phenyl hydrazide compound(EC50=60-115 nM) with significant neurotrophic properties related to the induction of brain-derived neurotrophic factor (BDNF).
-
Menin-MLL inhibitor ...
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
-
PBRM1-BD2-IN-7
PBRM1-BD2-IN-7, a selective and cell-active inhibitor targeting the polybromo-1 (PBRM1) bromodomain, demonstrates inhibitory efficacy against PBRM1-BD2 with an IC50 value of 0.29 μM.
